Trials / Completed
CompletedNCT06387472
DermAI to Evaluate Human Factor of Testing
Adaptive Deployment of DermAI to Evaluate Human Factor of Testing
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 151 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research is to improve how well remote patch allergy testing works and make sure they are easy and practical for people to use from home.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AI algorithm to evaluate photographs of skin test patch regions | Interpretation of skin test patch regions via artificial intelligence (AI) |
| DEVICE | Allergen Patch | Contains dime-sized disks which have different substance to which a person may be allergic. Two different patches were used due to the number of allergens being tested. Each patch can only hold 10 allergens and 14 allergens were tested in patients. |
Timeline
- Start date
- 2024-05-08
- Primary completion
- 2024-08-23
- Completion
- 2024-12-13
- First posted
- 2024-04-29
- Last updated
- 2025-09-10
- Results posted
- 2025-09-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06387472. Inclusion in this directory is not an endorsement.